Skip to main content
. Author manuscript; available in PMC: 2009 Nov 26.
Published in final edited form as: Ther Drug Monit. 2008 Oct;30(5):591–596. doi: 10.1097/FTD.0b013e3181858169

TABLE 1.

Demographics and Biochemical Variables of Study Participants (n = 8)

CsA TRL
Age (yrs) 46 ± 9
Gender (male/female) 4/4
Race (White/Asian) 7/1
Living donor/deceased donor transplant 5/3
Time after transplant (mo) 20 ± 14
Serum creatinine (mg/dL) 1.15 ± 0.27 1.13 ± 0.27
Creatinine clearance (mL/min)* 98 ± 40 101 ± 40
Albumin (g/dL) 3.8 ± 0.3 3.8 ± 0.3
Hemoglobin (g/dL) 12.7 ± 1.0 12.3 ± 1.0
Hemoglobin A1c (%) 7.6 ± 1.8 7.6 ± 1.8
Weight (kg) 85.9 ± 20.7 86.9 ± 20.7
CsA daily dose (mg/kg) 3.24 ± 0.82
CsA trough concentration (ng/mL) 127 ± 31
TRL daily dose (mg/kg) 0.07 ± 0.02
TRL trough concentration (ng/mL) 8.5 ± 3.4
Prednisone daily dose (mg/kg) 0.11 ± 0.09 0.10 ± 0.09

Data are numbers or mean ± SD.

*

Creatinine clearance calculated by Cockroft–Gault equation19